MIAMI – May 9, 2025 – PharmaForceIQ is pleased to announce that Chief Strategy Officer, Hemal Somaiya, has been selected by PM360 as an honoree in the ‘Disrupter’ category of the 2025 PM360 ELITE 100 program.
For 11 years running, the annual PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) 100 Awards have recognized individuals who have made a significant impact on the healthcare and life sciences industries. PM360 celebrates executives whose careers are defined by a lasting commitment to helping people live better lives, and honorees span various roles across healthcare, pharmaceuticals, medical devices, and service provider organizations.
Hemal Somaiya is currently the Chief Strategy Officer at PharmaForceIQ. This SaaS company is transforming the way the life sciences industry engages customers, displacing the traditional marketing and media buying models and driving substantial improvements in campaign efficiency across the product lifecycle. She has been recognized for her achievements as a marketing leader and visionary innovator who is not afraid to disrupt the status quo.
“I’m honored to be recognized alongside so many other impactful leaders who are driving change in our industry,” said Hemal Somaiya. “I’m passionate about the many ways that technology can help us all improve customer experience, make marketing more efficient, and drive better health outcomes. It’s been an incredible journey to work with clients across the industry for more than five years to turn that vision of a new path forward into a reality.”
From launching blockbuster global brands to helping growing and mature brands navigate a variety of market pressures, Hemal has deep experience across the product lifecycle in oncology, rare diseases, cardiology, and other therapeutic areas. That includes past marketing leadership roles at Merck, AstraZeneca, and other companies.
“Hemal has been committed to creating a better future for pharma marketing and customer engagement for many years,” said Stephen Onikoro, Chief Operating Officer at PharmaForceIQ. “We’re thrilled to see her recognized for making waves as a disrupter who is upending traditional models and applying technology in new ways to create change quickly in a historically slow-moving industry.”
The 2025 PM360 ELITE 100 honorees are featured in PM360‘s May issue and will be honored at an event in New York City on June 24, 2025. Visit the PM360 website to see the full list of honorees here.
About PharmaForceIQ
PharmaForceIQ is the fastest growing independent provider of precision omnichannel marketing solutions for the Life Science industry. The company uses a proprietary set of machine learning technologies. Unique data solutions connect the dots, end-to-end, in the pharma marketing ecosystem offering real-time omnichannel deployment in a way which prioritizes privacy and compliance, while also generating a clear return on investment for clients. Visit www.pharmaforceiq.com.
